| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/27/2004 | US6682736 Human monoclonal antibodies to CTLA-4 |
| 01/27/2004 | US6682735 Anti-IgE antibodies |
| 01/27/2004 | US6682734 Anti-cd20 derived from transfectoma having atcc deposit numbers 69119 and hbe 1388 respectively; depletion of peripheral blood b cells |
| 01/27/2004 | CA2105644C Resurfacing of rodent antibodies |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008140A2 Plasma urotensin in human heart failure |
| 01/22/2004 | WO2004008099A2 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007717A1 Proteomic screen to identify disease-related biological molecules and inhibitors thereto |
| 01/22/2004 | WO2004007711A1 Novel proteins and use thereof |
| 01/22/2004 | WO2004007703A1 Replicability virus which can express anti-tumour antibody with high efficiency and the use of it |
| 01/22/2004 | WO2004007701A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | WO2004007697A2 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | WO2004007685A2 Methods of modifying behavior of cd9-expressing cells |
| 01/22/2004 | WO2004007679A2 Dendritic cell pontentiation |
| 01/22/2004 | WO2004007555A2 Detection of prion disease |
| 01/22/2004 | WO2004007554A1 Protein for diagnosing diabetic retinopathy |
| 01/22/2004 | WO2004007553A1 Antibodies anti-c5 component of the complement system and their use |
| 01/22/2004 | WO2004007550A1 Mcam inhibitors |
| 01/22/2004 | WO2004007538A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/22/2004 | WO2004007520A2 Methods and compositions for preventing oxidative degradation of proteins |
| 01/22/2004 | WO2004006955A1 Super humanized antibodies |
| 01/22/2004 | WO2004006898A2 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 01/22/2004 | WO2004006860A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006839A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | WO2004006753A2 Sga-72m, a cancer associated antigen, and uses thereof |
| 01/22/2004 | WO2003099104A3 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma |
| 01/22/2004 | WO2003092615A3 Use of anti-cd1 antibodies for the modulation of immune responses |
| 01/22/2004 | WO2003090778A3 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/22/2004 | WO2003086300A3 Methods and compositions for treating alzheimer's disease |
| 01/22/2004 | WO2003086289A3 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
| 01/22/2004 | WO2003074679A3 Antibody optimization |
| 01/22/2004 | WO2003074569A3 Bispecific antibody point mutations for enhancing rate of clearance |
| 01/22/2004 | WO2003072800A3 Haemophilus adherence and penetration proteins |
| 01/22/2004 | WO2003070933A3 Process of cell electrofusion |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2003048303A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003044058A3 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis |
| 01/22/2004 | WO2003041637A3 Lyophilized monoclonal antibody compositions |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040016023 Modification of plant cell wall component and method of regulating development differentiation |
| 01/22/2004 | US20040016007 The chimeric mice can be immunized over a long time and enable one to obtain human antibodies against arbitrary antigens containing a human self-component |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040016004 Novel gene (designated 238P1B2), its encoded protein, and variants thereof exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides diagnostic, prophylactic, therapeutic target for cancer |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014943 Antibodies for detecting microorganisms |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014637 Mechanism for the inactivation of insulin receptor and uses in the treatment of type II diabetes |
| 01/22/2004 | US20040014207 Dendritic cell potentiation |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014156 Comprises immunoglobulin which binds and can be utilized to determine concentration and/or accelerate clearance of polyethylene glycol containing compound; monitoring cell toxicity; immunotherapy; antitumor agents |
| 01/22/2004 | US20040014145 Monoclonal antibody with affinity to defective transferrin for diagnosing alcoholism; immunoassay |
| 01/22/2004 | US20040014138 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014107 RNP immunoprecipitation assay |
| 01/22/2004 | US20040014089 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014028 Method for determination of protective epitopes for vaccination, diagnosis and vaccine quality control |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013683 Polypeptide viricides; genetic engineering |
| 01/22/2004 | US20040013680 Neurotoxic oligomers |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013672 Recombinant antibodies, and compositions and methods for making and using the same |
| 01/22/2004 | US20040013671 Diagnosis, therapy of infections using labeled antibody |
| 01/22/2004 | US20040013669 Method for treating persistent pain and identifying compounds to treat persistent pain |
| 01/22/2004 | US20040013667 Treatment with anti-ErbB2 antibodies |
| 01/22/2004 | US20040013666 Using antibodies; blocking receptors; anticoagulants |
| 01/22/2004 | US20040013665 Immunoreactive peptides from Epstein-Barr virus |
| 01/22/2004 | US20040013657 Novel nucleic acids and polypeptides |
| 01/22/2004 | US20040013647 Methods and compositions for treating a plaque-forming disease |
| 01/22/2004 | US20040013640 Antitumor agents; rheumatic agents; antiarthritic agents; tissue factor protein binding to antibody |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/22/2004 | DE10230631A1 Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen Uses of binding of NGAL substances for the diagnosis and treatment of cancer |
| 01/22/2004 | DE10230223A1 Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern Microparticles with CD28-specific monoclonal antibodies |
| 01/22/2004 | DE10229907A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 01/22/2004 | DE10229906A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2492980A1 Protein for diagnosing diabetic retinopathy |
| 01/22/2004 | CA2492787A1 Plasma urotensin in human heart failure |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492559A1 Mcam inhibitors |
| 01/22/2004 | CA2492475A1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 01/22/2004 | CA2492383A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 01/22/2004 | CA2492143A1 Methods and compositions for preventing oxidative degradation of proteins |
| 01/22/2004 | CA2491279A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |